The cholesterol monitors market is projected to grow from USD 2.8 billion in 2025 to USD 4.3 billion by 2035, at a CAGR of 4.6%. Single-Sided COD Chip-On-Flex will dominate with a 57.6% market share, while medical will lead the end users segment with a 41.3% share.